Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

NCT02346617 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Due to the KoreaFDA issue

Conditions

Cytomegalovirus Infections

Interventions

BIOLOGICAL: IFN-γ positive selected T-cells

Sponsor

Yae-Jean Kim

Collaborators

[object Object]